SCHEMBL2137065

SCHEMBL2137065

N#Cc1ccc2nc(-c3ccccc3)oc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.54
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
MAPT P10636 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CEPT1 Q9Y6K0 1/20 0.52
CASP3 P42574 3/20 0.50
SENP7 Q9BQF6 3/20 0.50
SENP6 Q9GZR1 3/20 0.50
SENP8 Q96LD8 2/20 0.50
KDM4E B2RXH2 2/20 0.49
HPGD P15428 2/20 0.49
POLB P06746 1/20 0.49
GPR119 Q8TDV5 8/20 0.48
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
GLA P06280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25544763 0.89 CEPT1 (0.48) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL28868337 0.88 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL25544761 0.86 NPC1 (0.46) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL28698089 0.85 GPR119 (0.49) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL23150838 0.85 GPR119 (0.51) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL24038264 0.84 ESR1 (0.51) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL13067482 0.81 HDAC6 (0.56) SMN1; SMN2NPC1RAB9ACEPT1CASP3
SCHEMBL18935925 0.81 KIF11 (0.51) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL23667719 0.81 GPR119 (0.46) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL9680833 0.81 NPC1 (0.63) SMN1; SMN2NPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109180590-A A method of Benzoheterocyclic compounds are quickly prepared using physical grinding method under room temperature solvent-free 福建医科大学 2019-01-11 CN disclosed
US-8242278-B2 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-14 US disclosed
US-20120101278-A1 PROCESS FOR PRODUCING BIARYL COMPOUND HAGIYA KOJI (JP) 2012-04-26 US disclosed
EP-1473286-B1 PROCESS FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL CO (JP) 2009-11-04 EP disclosed
US-20090216017-A1 PROCESS FOR PRODUCING BIARYL COMPOUND HAGIYA KOJI 2009-08-27 US disclosed
US-7554000-B2 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-30 US disclosed
US-20050096471-A1 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-05-05 US disclosed
EP-1473286-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101278-A1 PROCESS FOR PRODUCING BIARYL COMPOUND PPOX, CAT, TYR SMN1; SMN2 4152/4885NPC1 4102/4885RAB9A 2254/4885
US-20090216017-A1 PROCESS FOR PRODUCING BIARYL COMPOUND PPOX, CAT, TYR SMN1; SMN2 4152/4885NPC1 4102/4885RAB9A 2254/4885
US-20050096471-A1 Process for producing biaryl compound PPOX, CAT, TYR SMN1; SMN2 4152/4885NPC1 4102/4885RAB9A 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.